We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current AMPE market cap is 147.6k. The company's latest EPS is USD -7.6029 and P/E is -0.02.
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -18.58M | -15.83M | -20.57M | -20.7M | -9.52M |
| Net Income | -13.63M | -15.89M | -17.08M | -16.34M | -8.63M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 14M | 22.88M | 38.83M | 13.59M | 5.74M |
| Total Liabilities | 7.56M | 5.37M | 11.54M | 1.8M | 2.38M |
| Total Equity | 6.44M | 17.51M | 27.28M | 11.79M | 3.36M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -15.38M | -14.73M | -14.09M | -21.13M | -8.56M |
| Investing | -22k | -63k | -97k | N/A | N/A |
| Financing | 14.35M | 25.61M | 30.73M | -111k | N/A |
| Market Cap | 147.6k |
| Price to Earnings Ratio | -0.02 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0.04 |
| Price to Book Ratio | 0.04 |
| Dividend Yield | - |
| Shares Outstanding | 1.14M |
| Average Volume (1 week) | 665 |
| Average Volume (1 Month) | 2.76k |
| 52 Week Change | -13.33% |
| 52 Week High | 0.56 |
| 52 Week Low | 0.13 |
| Spread (Intraday) | 0.12 (48%) |
| Company Name | Ampio Pharmaceuticals Inc (PK) |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.ampiopharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
